“Spinal Cord Lesions and Clinical Status in Multiple Sclerosis: A 1.5 T and 3 T MRI Study.” Stankiewicz JM, Neema M, Alsop DC, Healy BC, Arora A, Buckle GJ, Chitnis T, Guttmann CR, Hackney D, Bakshi R. J Neurol Sci, 279:99-105 (2009).
“3T MRI Relaxometry Detects T2 Prolongation in the Cerebral Normal-Appearing White Matter in Multiple Sclerosis.” Neema M, Goldberg-Zimring D, Guss ZD, Healey BC, Guttmann CR, Houtchens MK, Weiner HL. Horsfield MA, Hackney BD, Alsop D, Bakshi R. NeuroImage, 46:633-641 (2009).
“Neuropsychological and MRI Measures Predict Short-Term Evolution in Benign Multiple Sclerosis.” Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, Amato MP, De Stefano N. Neurology, 73:498-503 (2009).
“Investigation of Quantitative Magnetisation Transfer Parameters of Lesions and Normal Appearing White Matter in Multiple Sclerosis.” Cercignani M, Basile B, Spano B, Comanducci G, Fasano F, Caltagirone C, Nocentini U, Bozzali M. NMR Biomed, 22:646-653 (2009).
“Influence of Task Complexity During Coordinated Hand and Foot Movements in MS patients With and Without Fatigue. A Kinematic and Functional MRI study.” Rocca MA, Gatti R, Agosta F, Broglia P, Rossi P, Riboldi E, Corti M, Comi G, Filippi M. Journal of Neurology, 256:470-482 (2009).
“A Functional Form for Injected MRI Gd-Chelate Contrast Agent Concentration Incorporating Recirculation, Extravasation and Excretion.” Horsfield MA, Thornton JS, Gill A, Jager HR, Priest AN, Morgan B. Physics in Medicine and Biology, 54:2933-2949 (2009).
“Is a Preserved Functional Reserve a Mechanism Limiting Clinical Impairment in Pediatric MS Patients?” Rocca MA, Absinta M, Ghezzi M, Moiola L, Comi G, Filippi M. Human Brain Mapping, 30:2844-2851 (2009).
“White Matter Hemodynamic Abnormalities Precede Sub-Cortical Gray Matter Shanges in Multiple Sclerosis.” Varga A, Johnson G, Babb J, Herbert J, Grossman R, Inglese M. J Neurol Neurosurg Psychiatry, 282:28-33 (2009).
“State of the Cervical Section of the Spinal Cord in Patients with Remitting Multiple Sclerosis During Immunomodulatory Treatment.” Shipova EG, Spirin NN, Kasatkin DS, Shumakov EI, Stepanov IO. Neuroscience and Behavioral Physiology, 39:47-51 (2009).
“High-Resolution Longitudinal Assessment of Flow and Permeability in Mouse Glioma Vasculature: Sequential Small Molecule and SPIO Dynamic Contrast Agent MRI.” Pike MM, Stoops CN, Langford CP, Akella NS, Nabors LB, Gillespie GY. Magn Reson Med, 61:615-625 (2009).